Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

A legfontosabb adatok

Ki végzi
Cochlear
Hol
Chapel Hill, Englewood, Iowa City, New York, Palo Alto és Seattle (Egyesült Államok)Mind a 6 helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
60 fő, tervezett
Kezdés
2022. aug. 19.
Várható befejezés
2027. jún.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • The Cochlear™ Nucleus® Cochlear Implant (CI) System
A regiszteradat frissítve
2026. szeptember 30.

Ki vehet részt

Életkor
5 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 18 feltétel megnézéseKevesebb

Ki vehet részt

  • Individuals 18 years or older (Group A); Ear to be Implanted:; Severe sensorineural hearing loss (HL) defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL ; Aided Consonant-Nucleus-Consonant Test (CNC) score ≤5% and; Normal Hearing Ear:; Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
  • Children 5 years to 17 years, 11 months (Group B); Ear to be Implanted:; Severe sensorineural HL defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL; Aided CNC score ≤5% and; Normal Hearing Ear:; Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
  • Previous experience with a current conventional treatment option for unilateral [SSD] HL (HA, bone-conduction device, or CROS technology), if no previous experience a minimum trial period of two weeks is required
  • English spoken as a primary language
  • Willing and able to provide written informed consent

Ki nem vehet részt

  • Previous cochlear implantation
  • Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device
  • Active / chronic middle-ear infection; conductive HL in either ear
  • Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator
  • Duration of profound sensorineural HL >10 years per self-report
  • Ossification, abnormal cochlear nerve or any other cochlear anomaly that might prevent complete insertion of the electrode array
  • Hearing loss of neural or central origin, including auditory neuropathy
  • Unrealistic expectations on the part of the participant/family, regarding the possible benefits, risks, and limitations that are inherent as determined by the Investigator
  • Evidence of and/or suspected cognitive or developmental concern
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child or sibling
  • Cochlear employees or employees of Contract Research Organizations (CROs) or contractors engaged by Cochlear for the purposes of this investigation
  • Pregnant or breastfeeding women

Helyszínek itt: Egyesült Államok

  • University of North CarolinaChapel Hill, Egyesült Államok
  • Rocky Mountain Ear CenterEnglewood, Egyesült Államok
  • University of IowaIowa City, Egyesült Államok
  • New York Eye and Ear InfirmaryNew York, Egyesült Államok
  • Stanford UniversityPalo Alto, Egyesült Államok
  • Virginia Mason Medical CenterSeattle, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.

A vizsgálat csoportja

  • Children and adults with unilateral hearing loss/single-sided deafnessEgyéb csoport

    Kezelés: The Cochlear™ Nucleus® Cochlear Implant (CI) System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Post-approval, Prospective, Nonrandomized, Single-arm Multicenter Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
A regiszteradat frissítve
2026. szeptember 30.